News
The LENNY trial highlighted the system's efficacy and safety in children aged two to six years with type 1 diabetes.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback